J Biol Chem, Vol. 274, Issue 42, 29726-29732, October 15, 1999
Peroxynitrite Inactivates Tryptophan Hydroxylase via
Sulfhydryl Oxidation
COINCIDENT NITRATION OF ENZYME TYROSYL RESIDUES HAS MINIMAL
IMPACT ON CATALYTIC ACTIVITY*
Donald M.
Kuhn
§¶ and
Timothy J.
Geddes
From the
Department of Psychiatry and Behavioral
Neurosciences and § Center for Molecular Medicine and
Genetics, Wayne State University School of Medicine,
Detroit, Michigan 48201
 |
ABSTRACT |
Tryptophan hydroxylase, the initial and
rate-limiting enzyme in serotonin biosynthesis, is inactivated by
peroxynitrite in a concentration-dependent manner. This
effect is prevented by molecules that react directly with peroxynitrite
such as dithiothreitol, cysteine, glutathione, methionine, tryptophan,
and uric acid but not by scavengers of superoxide (superoxide
dismutase), hydroxyl radical (Me2SO, mannitol), and
hydrogen peroxide (catalase). Assuming simple competition kinetics
between peroxynitrite scavengers and the enzyme, a second-order rate
constant of 3.4 × 104 M
1
s
1 at 25 °C and pH 7.4 was estimated. The
peroxynitrite-induced loss of enzyme activity was accompanied by a
concentration-dependent oxidation of protein sulfhydryl groups.
Peroxynitrite-modified tryptophan hydroxylase was resistant to
reduction by arsenite, borohydride, and dithiothreitol, suggesting that
sulfhydryls were oxidized beyond sulfenic acid. Peroxynitrite also
caused the nitration of tyrosyl residues in tryptophan hydroxylase,
with a maximal modification of 3.8 tyrosines/monomer. Sodium
bicarbonate protected tryptophan hydroxylase from peroxynitrite-induced
inactivation and lessened the extent of sulfhydryl oxidation while
causing a 2-fold increase in tyrosine nitration. Tetranitromethane,
which oxidizes sulfhydryls at pH 6 or 8, but which nitrates tyrosyl residues at pH 8 only, inhibited tryptophan hydroxylase equally at
either pH. Acetylation of tyrosyl residues with
N-acetylimidazole did not alter tryptophan hydroxylase
activity. These data suggest that peroxynitrite inactivates tryptophan
hydroxylase via sulfhydryl oxidation. Modification of tyrosyl residues
by peroxynitrite plays a relatively minor role in the inhibition of
tryptophan hydroxylase catalytic activity.
 |
INTRODUCTION |
Tryptophan hydroxylase
(TPH,1 EC 1.14.16.4;
L-tryptophan,tetrahydrobiopterin:oxygen oxidoreductase
(5-hydroxylating)) is the initial and rate-limiting enzyme in the
biosynthesis of the neurotransmitter serotonin. The physiological roles
for serotonin are diverse and include modulation of sleep,
thermoregulation, and food intake (1). From a clinical perspective,
alterations in serotonin function have been implicated in several
neuropsychiatric disorders such as depression, obsessive-compulsive
disorder, and suicide (2). Alterations in TPH activity produce
corresponding changes in the synaptic levels of serotonin (3),
suggesting that TPH can have influences on serotonin neurochemical
function that extend well beyond its role in fulfilling the first step in serotonin synthesis from tryptophan. Drugs that cause long term
changes in TPH activity could well change serotonin synaptic function
to the detriment of normal physiological and behavioral function. For
example, the neurotoxic amphetamines methamphetamine and
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") significantly reduce TPH activity and serotonin levels (4). Long term abuse of these
drugs produces behavioral and psychiatric conditions indicative of
diminished serotonin function (5, 6). Because the effects of these
drugs include permanent neuronal damage in humans (7, 8), great
emphasis has been directed at achieving a better understanding of their
toxic mechanisms of action.
Nitric oxide (NO) has been implicated in a variety of toxic neuronal
effects, including those associated with methamphetamine and MDMA (9,
10), and TPH is known to be inactivated by NO (11-13). Apart from
exerting direct effects of its own, NO reacts with other radical
species such as superoxide to produce the peroxynitrite anion
(ONOO
; see Ref. 14). This possibility is also relevant to
the neurotoxic amphetamines because their damaging effects on neurons
can involve the superoxide radical (15-17). ONOO
may be
more toxic to cells and proteins than either of its precursors NO and
superoxide radical, and ONOO
has been implicated in
neuronal toxicity (18-19) and neurodegenerative diseases (20-23).
Effects on proteins that were initially attributed to NO have now been
shown to occur via the action of ONOO
arising from
NO/superoxide interactions (24, 25).
TPH is a member of the monooxygenase superfamily of enzymes that
includes tyrosine hydroxylase (TH) and phenylalanine hydroxylase (26).
It was shown recently that the dopamine neurotoxin MPTP inactivates TH
via an ONOO
-mediated nitration of enzyme tyrosyl residues
(27). Recalling that the neurotoxic properties of MPTP have also been
linked to NO (28), we were prompted to examine the possibility that
ONOO
could influence TPH activity. We report presently
that ONOO
inactivates TPH and causes the nitration of
enzyme tyrosyl residues. However, in contradiction to the effect of
ONOO
on TH (27), the ONOO
-induced oxidation
of enzyme sulfhydryl groups, not tyrosine nitration, mediates TPH inactivation.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Tryptophan, DTT, superoxide dismutase, DTPA,
DTNB, N-acetylimidazole, methionine, cysteine,
Me2SO, dithionite, glutathione, glutathione-agarose, sodium
arsenite, sodium bicarbonate, sodium borohydride, and uric acid were
obtained from Sigma. Catalase was a product of Roche Molecular
Biochemicals. Tetranitromethane was purchased from Aldrich.
Isopropyl-
-D-thiogalactopyranoside was obtained from
Gold Biotechnologies. Thrombin and pGEX vectors were obtained from
Amersham Pharmacia Biotech. Tetrahydrobiopterin was purchased from Dr.
Shircks' Laboratories (Jona, Switzerland). A monoclonal antibody
against nitrotyrosine was purchased from Cayman Chemical Co. (Ann
Arbor, MI), and horseradish peroxidase-linked goat anti-mouse IgGs were
products of Cappel. Enhanced chemiluminescence reagents were products
of DuPont NEN, and Bio-Max MR film was from Eastman Kodak Co.
Restriction endonucleases, T4 ligase, and T4 kinase were products of
New England Biolabs. All other reagents were obtained from commercial
sources in the highest possible qualities.
Cloning to TPH and Assay of Enzymatic Activity--
TPH was
cloned and expressed as a glutathione S-transferase fusion
protein as described previously (13, 29, 30). Both wild-type enzyme and
a deletional mutant constituting the catalytic domain of TPH (amino
acids 99-444) were expressed in BL-21 (Escherichia coli)
cells. The catalytic core of TPH retains the essential catalytic properties of the wild-type enzyme and has proved useful in mechanistic studies of the catalytic properties of the enzyme (13, 29, 30). Cells
transformed with the plasmid bearing the TPH cDNA were grown
overnight at 37 °C and induced with 0.1 mM
isopropyl-
-D-thiogalactopyranoside for 2 h at
30 °C. Bacteria were washed with 10% glycerol and resuspended in
0.1 volume of 50 mM Tris-HCl, pH 7.5. After sonication and centrifugation (40,000 × g) to sediment insoluble
material, the supernatants were adsorbed on GSH-agarose for 60 min at
4 °C. Affinity beads with immobilized TPH were washed three times
with 50 volumes of 50 mM Tris-HCl, pH 7.5, at 4 °C, and
TPH was removed from the glutathione S-transferase fusion
tag by digestion of bead-bound protein with thrombin protease (10 units
of protease/mg of protein) at room temperature for 2 h. The
cleaved TPH protein was separated from GSH affinity beads by filtration
through glass wool. TPH activity was assayed by measuring the formation
of 5-hydroxytryptophan from tryptophan as described previously (13,
29). The levels of protein were measured by the method of Bradford
(31).
Synthesis of ONOO
and Treatment of
TPH
--
ONOO
was prepared fresh daily
from acidified nitrite and hydrogen peroxide as described by Beckman
et al. (32). The ONOO
concentration was
measured as an increase in absorbance at 302 nm (
302 = 1700 M
1 cm
1).
ONOO
solutions were chromatographed over small columns of
granular manganese dioxide to remove hydrogen peroxide contamination.
The removal of the peroxide was confirmed by assay of chromatographed ONOO
preparations for hydrogen peroxide by the method of
Matsubara et al. (33). Enzyme preparations were exposed to
ONOO
in the presence of 50 mM potassium
phosphate buffer, pH 7.4, and 100 µM DTPA for 15 min at
25 °C. ONOO
was added to enzyme preparations as a
small volume bolus with a Hamilton syringe during vigorous mixing.
After exposure to ONOO
, enzyme solutions were diluted
5-fold with 50 mM phosphate buffer, pH 7.5. Residual TPH
activity was immediately determined. The pH of all enzyme solutions was
checked carefully to ensure that the alkaline ONOO
did
not cause it to vary above 7.4 during exposure. Agents tested for the
ability to protect TPH from the effects ONOO
(see below)
were added 5 min prior to ONOO
and remained present
throughout exposure. Controls for ONOO
addition to enzyme
solutions included 1.2 N NaOH or ONOO
preparations allowed to decompose at room temperature in 50 mM Tris-HCl, pH 7.4. Decomposition of ONOO
was monitored as decreases in absorbance at 302 nm.
Titration of TPH Sulfhydryls with DTNB--
The reactivity of
sulfhydryl groups in TPH was determined by titration with DTNB by the
method of Ellman (34), as modified by Riddles et al. (35).
TPH was treated with varying concentrations of ONOO
as
described above, and after dialysis against phosphate-buffered saline,
protein (5-7 µM) was denatured with 6 M
guanidine HCl and reacted with DTNB (200 µM) in
phosphate-buffered saline at room temperature for 90 min. The reaction
was monitored as an increase in absorbance at 412 nm. The concentration
of sulfhydryl groups was calculated using
412 = 13,700 M
1 cm
1 (35).
Nitration of Tyrosyl Residues--
TPH was treated with varying
concentrations of ONOO
, and after dialysis against
phosphate-buffered saline, proteins were exposed to SDS-polyacrylamide
gel electrophoresis and electroblotting to nitrocellulose (36).
Nitrated tyrosines were detected with the use of a
3-nitrotyrosine-specific monoclonal antibody (1:1000 dilution). The
presence of nitrotyrosines in TPH was visualized with enhanced
chemiluminescence. As controls, blots of ONOO
-modified
TPH were treated with 100 mM dithionite to reduce
nitrotyrosines to aminotyrosines (37), or TPH preparations treated with
decomposed ONOO
were tested for immunoreactivity with the
nitrotyrosine antibody. The extent of tyrosine nitration was also
measured spectrophotometrically as increases in absorbance at 430 nm
(
430 = 4400 M
1
cm
1) as described by Crow and Ischiropoulos (38).
Treatment of TPH with Tetranitromethane--
TPH was exposed to
varying concentrations of tetranitromethane (in ethanol) at either pH 6 or pH 8. TPH was diluted into the appropriate buffer (50 mM
potassium phosphate buffer for pH 6 or 8 conditions), and
tetranitromethane was added and allowed to react with the protein for
15 min at 30 °C. Enzyme samples were diluted 5-fold with 50 mM potassium phosphate buffer, pH 7.4, and assayed for
residual activity at pH 7.4 as described. Tetranitromethane-modified
tryptophan hydroxylase was also tested for sulfhydryl oxidation or for
tyrosine nitration as described above.
Other Methods--
TPH was treated with dopamine-quinone (39) or
NO (11, 12) as described previously. In some experiments, the
tyrosine-acetylating reagent N-acetylimidazole was tested
for effects on TPH activity. The oxidation state of sulfhydryl groups
in ONOO
-treated TPH was determined as described by Radi
et al. (40).
 |
RESULTS |
Effects of ONOO
on TPH Activity--
The catalytic
core deletion mutant of recombinant TPH was treated with
ONOO
, and the results are presented in Fig.
1. TPH was tested at concentrations of
0.625, 1.25, 5, and 10 µM over the same concentration
range of ONOO
. The data show that TPH is inactivated by
ONOO
in a manner that depends on the concentrations of
both reactants. The IC50 for inhibition of enzyme activity
was approximately 15 or 200 µM ONOO
when
the enzyme concentration was 0.625 or 10 µM,
respectively. Decomposed ONOO
did not have an effect on
TPH activity. Full-length TPH was also tested for its response to
ONOO
and did not differ from the catalytic core deletion
mutant (data not shown). The main effect of ONOO
concentration was significant for each enzyme concentration
(p < 0.01, ANOVA). Because the catalytic core form of
TPH retains the essential catalytic properties of native TPH (13, 29), all subsequent experiments used this recombinant enzyme
preparation.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Inactivation of TPH by
ONOO . TPH ( , 0.625; , 1.25; , 5; or , 10 µM) was incubated with the indicated concentrations of
ONOO in 50 mM potassium phosphate buffer, pH
7.5, containing 100 µM DTPA for 15 min at 25 °C.
Enzyme samples were diluted 5-fold, and the remaining TPH activity was
assayed immediately. The addition of decomposed ONOO was
also tested in the presence of 1.25 µM TPH ( ). The
results represent the means of 3-4 independent experiments carried out
in duplicate. S.E. are omitted for clarity and were never more than
10% of the mean.
|
|
Protection of TPH from ONOO
-induced
Inactivation--
Various reagents were tested for the ability to
prevent ONOO
-induced inactivation of TPH, and the results
are presented in Table I. It can be seen
that reagents that react directly with ONOO
, such as DTT,
cysteine, GSH, methionine, tryptophan, and uric acid, provided
significant protection of the enzyme from inactivation. The hydroxyl
radical scavenger Me2SO, the superoxide radical scavenger superoxide dismutase, and the hydrogen peroxide scavenger catalase did
not protect TPH from ONOO
-induced inactivation (Table I).
None of the reagents tested for protection had effects on TPH activity
in the absence of ONOO
.
View this table:
[in this window]
[in a new window]
|
Table I
Protection of TPH from ONOO -induced inactivation
TPH (1.25 µM) was incubated with ONOO for 15 min at 25 °C. Agents tested for protection were added 5 min prior to
ONOO . Enzyme samples were diluted 5-fold with 50 mM potassium phosphate buffer, pH 7.4, and assayed for
residual catalytic activity. None of the reagents tested for protection
had an effect on TPH activity in the absence of ONOO .
|
|
Kinetics of ONOO
Reaction with TPH--
By modeling
simple competition kinetics for the protection of various proteins from
ONOO
by different concentrations of GSH and methionine
(41), TPH was tested for inhibition by ONOO
in the
presence of varying concentrations of GSH and methionine, and the
results are shown in Fig. 2. The present
calculations assumed rate constants of k = 740 M
1 s
1 for GSH (42) and
k = 150 M
1 s
1
for methionine (43), at 25 °C and pH 7.4. Increasing concentrations of both GSH and methionine provided increasing levels of protection of
TPH from inactivation by ONOO
. It was estimated that the
rate constant of the ONOO
reaction with TPH was 3.4 × 104 M
1 s
1.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Rate constant between TPH and
ONOO . TPH (0.625 µM) was incubated for
15 min at 25 °C with increasing concentrations of methionine or GSH
in 50 mM potassium phosphate buffer, pH 7.5, containing 100 µM DTPA in the presence of 50 µM
ONOO . Enzyme samples were then diluted 5-fold and assayed
for remaining TPH activity. Fi represents the
fraction of protection of TPH in the presence of ONOO
scavengers (S); ks represents the rate
constants for the reaction of ONOO with the scavengers,
and kD represents the rate constant for the reaction
of ONOO with TPH. The plot of
Fi[TPH]/(1 Fi)ks versus
[S] results in a straight line with a slope of
1/kD, allowing the determination of
kD (40, 41, 55). The results represent the means of
3 independent experiments each for GSH and methionine carried out in
duplicate.
|
|
Effects of ONOO
on Sulfhydryl Groups in TPH--
TPH
(5-7 µM) was treated with the same concentration range
of ONOO
shown to inactivate catalytic activity, and the
effects on sulfhydryl reactivity were determined by titration with DTBN
under denaturing conditions. The data in Fig.
3 show that ONOO
caused a
concentration-dependent loss of sulfhydryls from TPH that
paralleled the loss of catalytic activity. Untreated TPH contained nine
titratable sulfhydryl groups per monomer, consistent with predictions
from the nucleotide sequence of the catalytic core deletional mutant
(44). Increasing concentrations of ONOO
resulted in the
progressive loss of reactive sulfhydryl groups such that at a
concentration of 0.1 mM ONOO
, the number of
reactive sulfhydryl groups was reduced to 2.6 mol/mol TPH subunit.
ONOO
concentrations of 200-500 µM caused
the complete loss of DTNB-reactive sulfhydryl groups from the treated
enzyme and completely inactivated catalytic activity. These results are
consistent with ONOO
being a strong sulfhydryl oxidant
and confirm that TPH is very sensitive to inactivation by sulfhydryl
oxidation (45). The oxidation status of TPH sulfhydryl groups after
ONOO
treatment was tested by reacting the modified enzyme
with sodium arsenite, sodium borohydride, and DTT. Borohydride and DTT
reduce disulfides, and arsenite reduces sulfenic acids to the RSH (40). The data in Table II show that
ONOO
-modified sulfhydryl groups in TPH were resistant to
reduction by DTT, borohydride, and arsenite and suggest that
ONOO
is oxidizing enzyme sulfhydryl groups beyond
sulfenic acid.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of ONOO on TPH activity
and sulfhydryl groups. TPH (1.25 µM) was exposed to
the indicated concentrations of ONOO in the presence of
50 mM potassium phosphate buffer, pH 7.5, containing 100 µM DTPA for 15 min at 25 °C. Aliquots of the enzyme
were removed, diluted 5-fold, and assayed for remaining TPH activity.
The remainder of the enzyme was denatured with 6 M
guanidine HCl, and enzyme sulfhydryl groups were titrated with 200 µM DTNB. The concentration of sulfhydryl groups was
determined using 412 = 13,700 M 1 cm 1, and the results are
expressed as number of sulfhydryl (SH) groups per TPH monomer. The
results represent the means ± S.E. of three independent
experiments carried out in duplicate.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Reduction of ONOO -oxidized TPH sulfhydryls with arsenite,
borohydride, and DTT
TPH (5 µM) was treated with 0.2 mM
ONOO in 50 mM potassium phosphate buffer, pH 7.4, containing 100 µM DTPA for 15 min at 25 °C.
Immediately following ONOO treatment, TPH was incubated with
37 mM sodium arsenite, 26 mM sodium
borohydride, or 10 mM DTT for 45 min at 37 °C as
described by Radi et al. (40). Samples were dialyzed against
phosphate-buffered saline for 60 min at room temperature and then
assayed for sulfhydryl content. Data represent the means ± S.E.
for four independent experiments carried out in duplicate.
|
|
ONOO
-induced Nitration of Tyrosyl Residues in
TPH--
TPH was treated with the same concentration range of
ONOO
shown to inactivate catalytic activity (Fig. 1), and
the effects on tyrosine nitration are presented in Fig.
4. The data show that ONOO
causes a concentration-dependent increase in tyrosine
nitration. At a cumulative concentration of 2 mM,
ONOO
caused the nitration of approximately 3.8 tyrosyl
residues/TPH monomer. The IC50 concentration of
ONOO
for inhibition of enzyme activity (15 µM) resulted in the nitration of approximately 0.2 tyrosyl residues/TPH monomer. The concentration of ONOO
that completely inactivated TPH activity (500 µM) caused
the nitration of 2 tyrosyl residues/TPH monomer. TPH modified by
ONOO
was also examined for nitration by reaction with a
monoclonal antibody against 3-nitrotyrosine, and the results are
presented in the inset of Fig. 4. The results agree with the
spectrophotometric studies and show that nitrotyrosine immunoreactivity
was increased in a concentration-dependent manner by
ONOO
. Immunoreactivity on blots was restricted to the
40-kDa TPH band. Evidence of higher molecular weight species was not
observed, suggesting that the formation of dityrosines in TPH after
ONOO
treatment was not occurring. The specificity of the
nitrotyrosine antibody was tested by incubating blots of nitrated TPH
with dithionite to reduce nitrotyrosines to aminotyrosines prior to
antibody addition. As predicted (37), the antibody no longer recognized
ONOO
-treated TPH (data not shown). The nitrotyrosine
antibody was also unreactive with TPH treated with decomposed
ONOO
(data not shown). Agents shown to prevent
ONOO
-induced inactivation of enzyme catalytic activity
(Table I) were also tested for their effects on tyrosine nitration. It
was observed that each protective reagent prevented tyrosine nitration. Finally, Me2SO, superoxide dismutase, and catalase, which
did not protect TPH from ONOO
-induced inactivation, were
without effect on the ONOO
-induced nitration of tyrosines
in TPH (data not shown).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of ONOO on nitration of
tyrosyl residues in TPH. TPH (5 µM) was incubated
with the indicated concentrations of ONOO in the presence
of 50 mM potassium phosphate buffer, pH 7.5, containing 100 µM DTPA for 15 min at 25 °C. ONOO was
added in 100 µM increments with vigorous mixing, with
2-min intervals between each addition. Aliquots of the enzyme were
removed and diluted 5-fold, and the remaining TPH activity was
determined. The remaining enzyme was measured spectrophotometrically at
430 nm, and the extent of tyrosine nitration was calculated using
430 = 4400 M 1
cm 1 (38). The results represent the means ± S.E. of
3-4 independent experiments carried out in duplicate and are expressed
as number of tyrosines nitrated per TPH monomer. The inset
shows the determination of tyrosine nitration with a monoclonal
antibody against nitrotyrosine after treatment of TPH (1.25 µM) with ONOO in concentrations of 0 mM (lane 1), 0.01 mM (lane
2), 0.02 mM (lane 3), 0.05 mM
(lane 4), 0.1 mM (lane 5), 0.2 mM (lane 6), 0.5 mM (lane
7), and 1.0 mM (lane 8). Molecular weight
markers are shown to the left of the nitrotyrosine
blot.
|
|
Effects of Sodium Bicarbonate on ONOO
-induced
Alterations in TPH--
Carbon dioxide reacts rapidly with
ONOO
to produce the nitrosoperoxocarboxylate
(ONOOCO2
) adduct (46-50). The
ONOOCO2
adduct is a better tyrosine
nitrating reagent than ONOO
and has been shown to enhance
protein tyrosine nitration while causing less sulfhydryl oxidation by
comparison to ONOO
(46, 50-52). The effects of sodium
bicarbonate (10 mM) on the ONOO
-induced
modification of TPH were tested, and the results are presented in Table
III. Bicarbonate significantly protected
TPH from ONOO
-induced catalytic inactivation and lessened
the extent of sulfhydryl oxidation. At the same time, bicarbonate
significantly increased ONOO
-induced tyrosine nitration
in TPH. Bicarbonate had no effect on TPH in the absence of
ONOO
(data not shown).
View this table:
[in this window]
[in a new window]
|
Table III
Effects of sodium bicarbonate on the ONOO -induced
modification of TPH
TPH was treated with 0.2 mM ONOO in 50 mM potassium phosphate buffer, pH 7.4, containing 100 µM DTPA for 15 min at 25 °C. Sodium bicarbonate was
added at a concentration of 10 mM and was present
throughout the incubation of TPH with ONOO . After exposure of
TPH to the various incubation conditions, aliquots were removed for
determination of remaining catalytic activity, remaining sulfhydryls,
and tyrosine nitration as described. Data represent the means ± S.E. for three independent experiments carried out in duplicate.
|
|
Effects of Tetranitromethane on TPH--
In view of
ONOO
reactivity with most amino acid residues (46),
particularly cysteines and tyrosines, and considering that virtually
all tyrosine nitrating reagents are also strong sulfhydryl oxidants,
tetranitromethane was tested for its effects on TPH in an attempt to
discern whether modification of tyrosyl or cysteinyl residues was
responsible for enzyme inhibition. Tetranitromethane is useful in this
regard because it nitrates tyrosyl residues with relative selectivity
at pH 8, and not at pH 6, whereas it oxidizes sulfhydryls at both pH 6 and 8 (53, 54). It was hypothesized that if tetranitromethane was more
inhibitory at pH 8 as compared with pH 6, the pH-dependent
nitrating activity of the reagent would be responsible. The results in
Fig. 5 show that tetranitromethane caused
a concentration-dependent inactivation of TPH at pH 6 and at pH 8. The overall effect of tetranitromethane was statistically significant (p < 0.001 by ANOVA), but the effect of pH
was not (p < 0.5 by ANOVA). The effect of
tetranitromethane on tyrosine nitration is shown in the
inset to Fig. 5. It can be seen that higher concentrations
of tetranitromethane were needed to detect nitration (as compared with
inhibition of enzyme activity). Tetranitromethane caused a substantial
increase in tyrosine nitration of TPH over the concentration range of
50-200 µM at pH 8. The nitrating effects of
tetranitromethane were very weak at pH 6, showing tyrosine nitration of
TPH that was only 4.6% of the nitration seen at pH 8 (measured as
relative pixel density by image analysis) at a concentration of 200 µM tetranitromethane. Finally, tetranitromethane oxidized
sulfhydryl groups at pH 6 and pH 8. The total number of sulfhydryl
groups per monomer was reduced by tetranitromethane (100 µM) from 9 in the untreated enzyme to 1.9 at pH 6 and to 2.3 at pH 8.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of tetranitromethane on TPH activity
and tyrosine nitration. TPH (5 µM) was mixed with 50 mM potassium phosphate buffer at pH 6 or pH 8 and then
incubated with the indicated concentrations of tetranitromethane in the
presence of 100 µM DTPA for 15 min at 25 °C. Aliquots
were removed and diluted 5-fold with 50 mM potassium
phosphate buffer, pH 7.5, and TPH was assayed for residual activity.
Results represent the means ± S.E. of 6 independent experiments
run in duplicate at each pH. The inset shows the
determination of tyrosine nitration with a monoclonal antibody against
nitrotyrosine after treatment with tetranitromethane. Note that the
concentrations of tetranitromethane used for tyrosine nitration
(inset) were higher than those used for inhibition of enzyme
activity. Tetranitromethane concentrations used for measures of
tyrosine nitration in the inset were 0 mM
(lane 1), 0.05 mM (lane 2), 0.1 mM (lane 3), and 0.2 mM (lane
4) for both panels. Molecular weight markers are shown to the
left of the nitrotyrosine blots. The extent of protein
nitration by 200 µM tetranitromethane at pH 6 was 4.6%
that seen at pH 8 (lane 4 in each panel, determined as
relative pixel density from image analysis).
|
|
Effects of Other Group-specific Reagents on TPH
Activity--
N-Acetylimidazole, a mild
tyrosine-acetylating agent (55, 56), was tested for its effects on TPH
activity, and the results are presented in Fig.
6. It can be seen that
N-acetylimidazole did not inhibit TPH catalytic activity at
any concentration tested (up to 20 mM). In fact, at lower
concentrations, N-acetylimidazole caused a small activation
of TPH. N-Acetylimidazole did not cause the nitration of
tyrosyl residues in TPH as measured by immunoblotting with a
nitrotyrosine monoclonal antibody (data not shown).
N-Acetylimidazole did show evidence of modifying tyrosines
in TPH by causing a decrease in tyrosine absorbance at 278 nm. Attempts
to quantify tyrosine modification by reversal of acetylation with
hydroxylamine (56) were not possible because of enzyme aggregation.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of N-acetylimidazole
on TPH activity. TPH (5 µM) was incubated with the
indicated concentrations of N-acetylimidazole in the
presence of 50 mM potassium phosphate buffer, pH 7.5, containing 100 µM DTPA for 15 min at 25 °C. Aliquots
were removed and diluted 5-fold, and the remaining TPH activity was
determined. The results represent the means ± S.E. of 3 experiments assayed in duplicate.
|
|
 |
DISCUSSION |
TPH is quite sensitive to inactivation by the ONOO
anion. The approximate IC50 of ONOO
for
enzyme inhibition was 15 µM at an enzyme concentration of 0.625 µM. It has been estimated that the bolus addition
of 0.25 mM ONOO
is roughly equivalent to a
steady-state level of 1.0 µM maintained for 7 min (32,
40). Considering that ONOO
can be formed in
vivo by the diffusion-limited reaction of NO and superoxide, TPH
could well be a target for ONOO
in vivo (see
below). TPH is known to be an extremely labile enzyme (45), and
reagents like NO or quinones, which target cysteinyl residues, are also
potent inhibitors of the enzyme (11-13, 39). ONOO
is a
powerful sulfhydryl oxidant (40), and this property alone leads to the
prediction that it would cause the inactivation of TPH. However,
ONOO
can also nitrate tyrosyl residues in proteins (57),
and this property of ONOO
has been implicated as the
mechanism by which the dopamine neurotoxin MPTP inhibits TH activity in
a model of Parkinson's disease (27). Based on the structural and
functional homologies among the monooxygenase family of enzymes, and
considering that ONOO
could play a role in the
amphetamine-induced inhibition of TPH, it was important to determine if
TPH contained catalytically important tyrosyl residues as appears to be
the case for TH (27).
Various agents were tested for the ability to protect TPH from
ONOO
-induced inactivation. DTT, GSH, cysteine,
methionine, tryptophan, and uric acid were very effective in this
regard, consistent with their known reactivities with
ONOO
(46, 58-60). It does not appear that the effect of
ONOO
on TPH activity is mediated by radicals or reactive
oxygen species because scavengers of hydroxyl radical
(Me2SO), hydrogen peroxide (catalase), or superoxide
(superoxide dismutase) did not protect the enzyme from inactivation.
The effect of tryptophan to protect TPH from inactivation by
ONOO
could indicate that the TPH substrate is protective
via its occupation of the enzyme-active site, but this possibility is
hard to substantiate in view of the direct reactivity of tryptophan
with ONOO
(46). Tryptophan is very effective in
protecting TPH from inactivation caused by the sulfhydryl reagents
N-ethylmaleimide and DTNB (45), and these results are
consistent with the location of a reactive sulfhydryl at the
enzyme-active site. By assuming that the inactivation of TPH by
ONOO
was the result of simple competition kinetics
between the two reactants, it was possible to calculate an apparent
second-order rate constant of 3.4 × 104
M
1 s
1 by including cysteine or
methionine as competing reagents. The rate constants of
ONOO
reaction with cysteine and methionine are well known
(41-43) in this regard. TPH was found to be moderately reactive with
ONOO
. Other enzymes, such as glyceraldehyde-3-phosphate
dehydrogenase, are remarkably sensitive to inactivation by
ONOO
(61). TPH is about 1 order of magnitude lower in
reactivity with ONOO
by comparison to
glyceraldehyde-3-phosphate dehydrogenase. TPH, on the other hand, is
similar to numerous other enzymes (e.g. aconitase, alcohol
dehydrogenase, aconitase) that are inactivated by ONOO
with similar reaction kinetics (25, 34, 62, 63).
The effects of ONOO
on TPH tyrosyl residues were
determined to examine whether catalytically important tyrosines were
mediating the loss of enzyme activity. Indeed, a good correlation was
observed between inactivation of TPH and nitration of tyrosines
measured spectrophotometrically or immunochemically with a
nitrotyrosine-specific monoclonal antibody. Increasing concentrations
of ONOO
led to greater inactivation of TPH activity as
well as increasing nitration of tyrosyl residues. ONOO
nitrated 3.8 tyrosines per enzyme subunit at a cumulative concentration of 2 mM. The catalytic core deletion mutant of TPH contains
a total of 15 tyrosyl residues (44), so it appears that the secondary structure of the protein and the charge of ONOO
act in
concert to limit accessibility of ONOO
to tyrosyl
residues within TPH. The IC50 for inactivation of TPH by
ONOO
was approximately 15 µM, and at this
concentration, it was calculated that approximately 0.2 tyrosyl
residues/monomer were nitrated.
ONOO
is a powerful sulfhydryl oxidant (42), and TPH is
very sensitive to inactivation by a variety of sulfhydryl reagents (11,
12, 39, 45). Therefore, the effects of ONOO
on sulfhydryl
groups in TPH were determined by DTNB titration. The nucleotide
sequence of the catalytic domain of TPH (residues 99-444) predicts
that each subunit of TPH contains 9 cysteinyl residues (44). Titration
of untreated TPH with DTNB produced results that were consistent with
this number. These results also indicate that all cysteine residues
within the catalytic domain deletion mutant of TPH are accessible to
solvent. Increasing concentrations of ONOO
led to
corresponding decreases in the number of titratable sulfhydryl groups
in the enzyme. At the IC50 for enzyme inhibition (15 µM), ONOO
oxidized approximately 6 of the
total of 9 cysteinyl residues in TPH. Concentrations of
ONOO
that completely inhibited TPH catalytic activity
(200-500 µM) caused the loss of all DTNB-reactive
sulfhydryl groups. It is possible that ONOO
modification
of TPH could cause a structural change in the enzyme that could bury
sulfhydryl groups. However, when ONOO
-treated TPH was
denatured with 6 M guanidine HCl, the enzyme was still
devoid of DTNB-reactive sulfhydryl groups. These results indicate that
ONOO
oxidizes all accessible sulfhydryl groups in TPH.
The extent of the ONOO
-induced oxidation of TPH
sulfhydryl groups was also apparent from attempts to reduce them after
ONOO
-induced modification. Oxidized sulfhydryl groups in
TPH were resistant to reduction by DTT, borohydride, and arsenite after treatment with ONOO
, indicating that enzyme sulfhydryls
were oxidized beyond sulfenic acid (40).
Results from studies of ONOO
on TPH alone cannot discern
whether the inactivation of TPH is mediated by sulfhydryl oxidation or
tyrosine nitration. Unfortunately, from a mechanistic point of view,
many tyrosine-nitrating reagents are also strong sulfhydryl oxidants
(e.g. ONOO
and 4-chloro-7-nitrobenzofurazan),
making it difficult to assess the role of tyrosyl residues selectively
in TPH catalysis. Therefore, bicarbonate was tested for its effects on
the ONOO
-induced modification of TPH. Carbon dioxide is
well known for its ability to enhance ONOO
-induced
protein tyrosine nitration and decrease sulfhydryl oxidation (46-52).
It was observed that bicarbonate protected TPH from the ONOO
-induced loss of catalytic activity and lessened the
extent of sulfhydryl oxidation. Under the same conditions, bicarbonate
significantly increased the ONOO
-induced nitration of
tyrosines in the enzyme. TPH was also treated with tetranitromethane, a
reagent that oxidizes sulfhydryls at pH 6 and 8 but which causes
tyrosine nitration only at pH 8 (53, 54). The results showed that TPH
was very sensitive to inactivation by tetranitromethane, but inhibition
by this reagent was the same at pH 6 and pH 8. The pH dependence of
tyrosine nitration by tetranitromethane supported catalytic studies
with TPH. It was observed that tetranitromethane caused increasing
nitration of tyrosyl residues in TPH at pH 8, but very little nitration
was observed at pH 6. Tetranitromethane caused extensive sulfhydryl
oxidation that was independent of pH, reducing TPH sulfhydryls from 9 to 2 at pH 6 or pH 8. These results with bicarbonate and
tetranitromethane do not support a substantial role for tyrosine
nitration in the inactivation of TPH, although we cannot rule out the
possibility that ONOO
,
ONOOCO2
, and tetranitromethane are
nitrating entirely distinct sets of tyrosine residues in TPH. Finally,
N-acetylimidazole, a mild, tyrosine-acetylating reagent, was
tested for its effects on enzyme activity. TPH was not altered by
N-acetylimidazole in concentrations up to 20 mM.
Taken together, these data suggest that tyrosyl residues in TPH do not
appear to play an influential role in its catalytic function.
TPH is a non-heme iron protein that can be inhibited by agents known to
chelate iron (39). Therefore, it is possible that ONOO
is
inhibiting TPH via attack at an active site Fe(II). This possibility is
diminished by two observations: first, all incubations of TPH with
ONOO
, ONOOCO2
, and
tetranitromethane included the iron chelator DTPA (32); second,
recombinant TPH is expressed in bacteria as an apoenzyme, essentially
free of iron that could serve as a target for ONOO
.
The present findings with TPH are surprising in at least one regard. TH
was recently reported to be inactivated by MPTP via a process that
involved ONOO
-induced nitration of tyrosyl residues (27).
This finding is interesting because it reveals a potential mechanism by
which a dopamine neurotoxin acts upon this important enzyme. In
addition, the drug-induced posttranslational modification of TH leaves
a footprint of ONOO
(or other reactive nitrating species)
action in the enzyme that could be detected by in vitro
analysis. Given the sequence and functional homologies shared between
TH and TPH (26), we predicted that TPH would also be inactivated by
ONOO
via modification of catalytically important
tyrosines. Such an effect would be important and useful in
investigations of the mechanisms of action of the neurotoxic
amphetamines, whose effects include inactivation of TPH and damage to
serotonin neurons (4, 7). However, nitration of TPH by
ONOO
was not indicative of catalytic function. On the
other hand, several results point to sulfhydryls as important
determinants of TPH catalytic activity. First, the kinetic and
protection studies showed that sulfhydryl reductants are very effective
in preventing ONOO
-induced inactivation of TPH. Second,
ONOO
caused an extensive oxidation of enzyme sulfhydryl
groups, and loss of TPH activity paralleled the loss of sulfhydryl
reactivity more closely than nitration of tyrosyl residues. Third,
bicarbonate protected TPH from ONOO
-induced loss of
catalytic activity and sulfhydryl oxidation while, at the same time,
causing increased tyrosine nitration. Finally, the inhibitory effects
on TPH of tetranitromethane were the same at pH 6 and pH 8. The
tyrosine nitrating properties of tetranitromethane are evident at pH 8, not at pH 6, whereas it oxidizes sulfhydryls equally at either pH.
Because tetranitromethane was no more inhibitory at pH 8 than at pH 6, it appears that the pH-dependent nitration of tyrosines (in
addition to sulfhydryl oxidation) did not contribute to TPH inactivation.
These results reaffirm the importance of cysteinyl residues in TPH
catalytic function (13, 45). The precise roles of cysteines in TPH
catalysis are not known, and with 10 cysteinyls/monomer in the
full-length enzyme (44), elucidation of their roles will be difficult.
Our results also establish that TPH can be nitrated at tyrosyl residues
by ONOO
. These findings will be useful to establish if
drugs like methamphetamine and MDMA, which are known to inactivate TPH
and cause damage to serotonin neurons in vivo (4), leave an
ONOO
(or other reactive nitrogen species) footprint in
TPH in the form of nitrotyrosines. Finally, the present results with
TPH have led us to reevaluate the ONOO
-induced
inactivation of TH to determine if these closely related enzymes differ
in the manner by which tyrosyl residues influence their respective
catalytic activities.
 |
ACKNOWLEDGEMENT |
We thank Dr. Bruce A. Freeman for advice on
peroxynitrite and thoughtful comments on the data in this paper.
 |
FOOTNOTES |
*
This work was supported by National Institute on Drug Abuse
Research Grant DA10756.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom reprints and correspondence should be addressed: 2125 Scott Hall, 540 E. Canfield, Detroit, MI 48201. Tel./Fax: 313-577-9737; E-mail: donald.kuhn@wayne.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
TPH, tryptophan
hydroxylase;
DTT, dithiothreitol;
MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
MDMA, 3,4-methylenedioxymethamphetamine;
NO, nitric oxide,
ONOO
, peroxynitrite;
TH, tyrosine hydroxylase;
DTNB, 5,5'-dithiobis(2-nitrobenzoic acid);
DTPA, diethylenetriaminepentaacetic acid;
ANOVA, analysis of variance.
 |
REFERENCES |
| 1.
|
Whitaker-Azmitia, P. M.,
and Peroutka, S. J.
(1990)
Ann. N. Y. Acad. Sci.
600,
1-715[CrossRef]
|
| 2.
|
Paul, S. M.
(1990)
J. Clin. Psychiat.
51,
1-70
|
| 3.
|
Gartside, S. E.,
Cowen, P. J.,
and Sharp, T.
(1992)
Psychopharmacology
109,
251-253[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Gibb, J. W.,
Johnson, M.,
Elayan, I.,
Lim, H. K.,
Matsuda, L.,
and Hanson, G. R.
(1997)
NIDA Res. Monogr.
173,
128-145[Medline]
[Order article via Infotrieve]
|
| 5.
|
McCann, U. D.,
Ridenour, A.,
Shaham, Y.,
and Ricaurte, G. A.
(1994)
Neuropsychopharmacology
10,
129-138[Medline]
[Order article via Infotrieve]
|
| 6.
|
Steele, T. D.,
McCann, U. D.,
and Ricaurte, G. A.
(1994)
Addiction
89,
539-551[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
McCann, U. D.,
Szabo, Z.,
Scheffel, U.,
Dannals, R. F.,
and Ricaurte, G. A.
(1998)
Lancet
352,
1433-1437[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
McCann, U. D.,
Wong, D. F.,
Yokoi, F.,
Villemagne, V.,
Dannals, R. F.,
and Ricaurte, G. A.
(1998)
J. Neurosci.
18,
8417-8422[Abstract/Free Full Text]
|
| 9.
|
Zheng, Y.,
and Laverty, R.
(1998)
Brain Res.
795,
257-263[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Itzhak, Y.,
Gandia, C.,
Huang, P. L.,
and Ali, S. F.
(1998)
J. Pharmacol. Exp. Ther.
284,
1040-1047[Abstract/Free Full Text]
|
| 11.
|
Kuhn, D. M.,
and Arthur, R. E., Jr.
(1996)
J. Neurochem.
67,
1071-1077
|
| 12.
|
Kuhn, D. M.,
and Arthur, R. E., Jr.
(1997)
J. Neurochem.
68,
1495-1502[Medline]
[Order article via Infotrieve]
|
| 13.
|
Kuhn, D. M.,
and Arthur, R. E., Jr.
(1997)
J. Neurosci.
17,
7245-7251[Abstract/Free Full Text]
|
| 14.
|
Huie, R. E.,
and Padmaja, S.
(1993)
Free Radical Res. Commun.
18,
195-199[Medline]
[Order article via Infotrieve]
|
| 15.
|
Acikgoz, O.,
Gonenc, S.,
Kayatekin, B. M.,
Uysal, N.,
Pekcetin, C.,
and Semin, I.
(1998)
Brain Res.
813,
200-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Hirata, H.,
Asanuma, M.,
and Cadet, J. L.
(1998)
Mol. Brain Res.
58,
209-216[Medline]
[Order article via Infotrieve]
|
| 17.
|
Cadet, J. L.,
Ladenheim, B.,
Hirata, H.,
Rothman, R. B.,
Carlson, E.,
Epstein, C.,
and Moran, T. H.
(1995)
Synapse
21,
169-176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Reist, M.,
Marshall, K. A.,
Jenner, P.,
and Halliwell, B.
(1998)
J. Neurochem.
71,
2431-2438[Medline]
[Order article via Infotrieve]
|
| 19.
|
Bolanos, J. P.,
Almeida, A.,
Stewart, V.,
Peuchen, S.,
Land, J. M.,
Clark, J. B.,
and Heales, S. J. R.
(1997)
J. Neurochem.
68,
2227-2240[Medline]
[Order article via Infotrieve]
|
| 20.
|
Beal, M. F.,
Ferrante, R. J.,
Browne, S. E.,
Matthews, R. T.,
Kowall, N. W.,
and Brown, R. H., Jr.
(1997)
Ann. Neurol.
42,
644-654[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Hooper, D. C.,
Spitsin, S.,
Kean, R. B.,
Champion, J. M.,
Dickson, G. M.,
Chaudhry, I.,
and Koprowski, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
675-680[Abstract/Free Full Text]
|
| 22.
|
Smith, M. A.,
Richey Harris, P. L.,
Sayre, L. M.,
Beckman, J. S.,
and Perry, G.
(1997)
J. Neurosci.
17,
2653-2657[Abstract/Free Full Text]
|
| 23.
|
Beckman, J. S.,
and Koppenol, W. H.
(1996)
Am. J. Physiol.
271,
C1424-C1437[Abstract/Free Full Text]
|
| 24.
|
Hausladen, A.,
and Fridovich, I.
(1994)
J. Biol. Chem.
269,
29405-29408[Abstract/Free Full Text]
|
| 25.
|
Castro, L.,
Rodriguez, M.,
and Radi, R.
(1994)
J. Biol. Chem.
269,
29409-29415[Abstract/Free Full Text]
|
| 26.
|
Grennet, H. E.,
Ledley, F. D.,
Reed, L. L.,
and Woo, S. L. C.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
5530-5534[Abstract/Free Full Text]
|
| 27.
|
Ara, J.,
Przedborski, S.,
Naini, A. B.,
Jackson-Lewis, V.,
Trifiletti, R. R.,
Horwitz, J.,
and Ischiropoulos, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7659-7663[Abstract/Free Full Text]
|
| 28.
|
Przedborski, S.,
Jackson-Lewis, V.,
Yokoyama, R.,
Shibata, T.,
Dawson, V. L.,
and Dawson, T. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4565-4571[Abstract/Free Full Text]
|
| 29.
|
Kuhn, D. M.,
Arthur, R.,
and States, J. C.
(1997)
J. Neurochem.
68,
2220-2223[Medline]
[Order article via Infotrieve]
|
| 30.
|
D'Sa, C. M.,
Arthur, R. E., Jr.,
and Kuhn, D. M.
(1996)
J. Neurochem.
67,
917-926[Medline]
[Order article via Infotrieve]
|
| 31.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Beckman, J. S.,
Chen, J.,
Ischiropoulos, H.,
and Crow, J. P.
(1994)
Methods Enzymol.
233,
229-240[Medline]
[Order article via Infotrieve]
|
| 33.
|
Matsubara, C.,
Nishikawa, Y.,
Yoshida, Y.,
and Takamura, K.
(1983)
Anal. Biochem.
130,
128-133[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Ellman, G. L.
(1959)
Arch. Biochem. Biophys.
82,
70-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Riddles, P. W.,
Blakeley, R. L.,
and Zerner, B.
(1993)
Methods Enzymol.
91,
49-60
|
| 36.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Ye, Y. Z.,
Strong, M.,
Huang, Z. Q.,
and Beckman, J. S.
(1996)
Methods Enzymol.
269,
201-209[Medline]
[Order article via Infotrieve]
|
| 38.
|
Crow, J. P.,
and Ischiropoulos, H.
(1996)
Methods Enzymol.
269,
185-194[Medline]
[Order article via Infotrieve]
|
| 39.
|
Kuhn, D. M.,
and Arthur, R., Jr.
(1998)
J. Neurosci.
18,
7111-7117[Abstract/Free Full Text]
|
| 40.
|
Radi, R.,
Beckman, J. S.,
Bush, K. M.,
and Freeman, B. A.
(1991)
J. Biol. Chem.
266,
4244-4250[Abstract/Free Full Text]
|
| 41.
|
Radi, R.
(1996)
Methods Enzymol.
269,
354-366[Medline]
[Order article via Infotrieve]
|
| 42.
|
Koppenol, W. H.,
Pryor, W. A.,
Moreno, J. J.,
Ischiropoulos, H.,
and Beckman, J. S.
(1992)
Chem. Res. Toxicol.
5,
834-842[CrossRef] |